Contract facts
UnrestrictedTO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION. is a federal Unrestricted award for National Institutes Of Health Niaid held by Arisan Therapeutics Inc. Estimated value $23.9M ($2.9M obligated). Current period of performance ends Jun 30, 2027. Last award drew 20 bidders. Place of performance: CARLSBAD CA. Related solicitation HHS-NIH-NIAID-BAA2025-1.
TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.
Recompete timing
PublicCurrent PoP ends Jun 30, 2027 (276 days remaining). Agencies typically plan 12–18 months ahead — at 9.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N93026C00012? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordArisan Therapeutics Inc — $3.7M obligated across 3 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93026C00012?
75N93026C00012 (Develop a therapeutic SMALL molecule VIRAL) is a National Institutes Of Health Niaid award with a potential value of $23.9M, currently held by Arisan Therapeutics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93026C00012?
National Institutes Of Health Niaid awarded 75N93026C00012 to Arisan Therapeutics Inc (potential $23.9M).
Who is the incumbent on 75N93026C00012?
Arisan Therapeutics Inc is the incumbent with $3.7M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Jun 30, 2027.
When does Arisan Therapeutics Inc’s 75N93026C00012 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N93026C00012? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.